PROS1 and cancer: By preventing SFK myristoylation and promoting their proteolytic degradation (and that of other myristoylated signaling proteins) [19], PCLX-001 represents an alternative approach for targeting SFKs and signal transduction from RTKs at the source in a novel and quasi-permanent manner, thereby impacting cancer cell growth.